Sight Sciences Inc (SGHT) is a Healthcare · Medical Devices company listed on NASDAQ. Price $8.13 (+0.62%), Market cap $0.26B, 52-week low–high $3.20 ~ $9.05.
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device
Financial statements, price targets, institutional (13F) holdings and related news for Sight Sciences Inc are updated in real time on BlackAll Trade.
Sight Sciences Inc trades at $8.13 (+0.62%). Real-time quotes and charts are available on BlackAll Trade.
Sight Sciences Inc has a market cap of about $0.26B.
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the